Cell Line Development Market worth $3.96 Billion
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
(firmenpresse) - According to the new market research report & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019", published by MarketsandMarkets
Don
Early buyers will receive 10% customization on reports.
This report studies the global cell line development market for the forecast period of 2014 to 2019.This market is expected to reach $3.96 billion by 2019 from$2.2 billionin 2014, and is poised to grow at a CAGR of 12.5% from 2014 to 2019.
The global cell line development market is segmented on the basis of products, type of cell lines, source of cell lines, applications, and geographies.
Based on products, the cell line development market is categorized into equipment, and media &reagents.The media and reagents segment is expected to account for a major share of the cell line development market, by product in 2014.
The media and reagents segment is further divided into serum, media, and reagents.The reagents segment is expected to account for the largest share of the cell line development market in 2014.
The cell line development market, by type is further segmented into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines are expected to account for a major share of the cell line development market in 2014.
On the basis of source of cell lines, the market is segmented into mammalian, insect, and amphibian. The cell lines derived from mammalian source are likely to account for the largest share of the cell line development market in 2014.
Bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery are the key application areas of cell lines. Bioproduction is expected to account for a major share among the application areas in the cell line development market.
Browse and in-depth TOC on
114 - Tables
64 - Figures
225 - Pages
View more detailed TOC (at) https://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html
On the basis of geography, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises of Latin America, Pacific countries, and Africa. North America holds the largest in the cell line development market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for cell line manufacturers.
Over the years, the demand for cell line development equipment and media and reagents is likely to increase owing to the increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies to develop cell lines. However, in spite of innovative technologies in the market, developing stable and authentic cell lines still remains a challenge. Increasing risk of pandemics and communicable diseases are expected to create opportunities for the development of cell lines.
Some of the major players in the global cell line development market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma-Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).
Request for Free Sample Report (at) http://bit.ly/2PbpmcP
Browse Adjacent Markets (at) Biotechnology Market Research Reports & Consulting
About MarketsandMarkets
MarketsandMarkets
Our 850 fulltime analyst and SMEs at MarketsandMarkets"Growth Engagement Model ". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets"Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-line-development-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 04.10.2018 - 14:06 Uhr
Sprache: Deutsch
News-ID 1542191
Anzahl Zeichen: 6500
contact information:
Contact person:
Town:
Phone:
Kategorie:
Healthcare & Medical
Typ of Press Release: Erfolgsprojekt
type of sending: Veröffentlichung
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 354 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cell Line Development Market worth $3.96 Billion
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
